| abstract |
The present invention relates to a nucleoside analog as shown in the following formula and a use thereof. Specifically, the present invention relates to a nucleoside analog as shown in the following formula, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition thereof, and a use thereof in preparing (a) inhibitors for inhibiting the replication of coronaviruses, paramyxoviruses, influenza viruses, flaviviruses, filoviruses, Bunya viruses and/or arenaviruses; and/or (b) drugs for treating and/or preventing and mitigating diseases caused by coronaviruses, paramyxoviruses, influenza viruses, flaviviruses, filoviruses, Bunya viruses and/or arenaviruses. |